Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Similar articles for PubMed (Select 14610118)

1.

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk.

Mayeux R, Honig LS, Tang MX, Manly J, Stern Y, Schupf N, Mehta PD.

Neurology. 2003 Nov 11;61(9):1185-90.

PMID:
14610118
2.

Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.

Tzikas S, Schlak D, Sopova K, Gatsiou A, Stakos D, Stamatelopoulos K, Stellos K, Laske C.

J Alzheimers Dis. 2014;39(3):557-64. doi: 10.3233/JAD-131469.

PMID:
24217274
3.

Survival of Alzheimer's disease patients in Korea.

Go SM, Lee KS, Seo SW, Chin J, Kang SJ, Moon SY, Na DL, Cheong HK.

Dement Geriatr Cogn Disord. 2013;35(3-4):219-28. doi: 10.1159/000347133. Epub 2013 Mar 1.

PMID:
23467314
4.

No diagnostic value of plasma clusterin in Alzheimer's disease.

Silajdžić E, Minthon L, Björkqvist M, Hansson O.

PLoS One. 2012;7(11):e50237. doi: 10.1371/journal.pone.0050237. Epub 2012 Nov 28.

5.

Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City Study.

Gabelle A, Richard F, Gutierrez LA, Schraen S, Delva F, Rouaud O, Buée L, Dartigues JF, Touchon J, Lambert JC, Berr C.

J Alzheimers Dis. 2013;33(2):381-91. doi: 10.3233/JAD-2012-121147.

6.

Potential utility of soluble p3-alcadein α plasma levels as a biomarker for sporadic Alzheimer's disease.

Kamogawa K, Kohara K, Tabara Y, Takita R, Miki T, Konno T, Hata S, Suzuki T.

J Alzheimers Dis. 2012;31(2):421-8. doi: 10.3233/JAD-2012-120601.

PMID:
22571980
7.

Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome.

Coppus AM, Schuur M, Vergeer J, Janssens AC, Oostra BA, Verbeek MM, van Duijn CM.

Neurobiol Aging. 2012 Sep;33(9):1988-94. doi: 10.1016/j.neurobiolaging.2011.08.007. Epub 2011 Sep 29.

8.

Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study.

Hansson O, Stomrud E, Vanmechelen E, Östling S, Gustafson DR, Zetterberg H, Blennow K, Skoog I.

J Alzheimers Dis. 2012;28(1):231-8. doi: 10.3233/JAD-2011-111418.

PMID:
21955816
9.

Alzheimer's disease and co-morbidity: increased prevalence and possible risk factors of excess mortality in a naturalistic 7-year follow-up.

Heun R, Schoepf D, Potluri R, Natalwala A.

Eur Psychiatry. 2013 Jan;28(1):40-8. doi: 10.1016/j.eurpsy.2011.06.001. Epub 2011 Sep 15.

PMID:
21924588
10.

Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer's disease.

Ijsselstijn L, Dekker LJ, Stingl C, van der Weiden MM, Hofman A, Kros JM, Koudstaal PJ, Sillevis Smitt PA, Ikram MA, Breteler MM, Luider TM.

J Proteome Res. 2011 Nov 4;10(11):4902-10. doi: 10.1021/pr200270z. Epub 2011 Sep 28.

PMID:
21879768
11.

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.

Han X, Rozen S, Boyle SH, Hellegers C, Cheng H, Burke JR, Welsh-Bohmer KA, Doraiswamy PM, Kaddurah-Daouk R.

PLoS One. 2011;6(7):e21643. doi: 10.1371/journal.pone.0021643. Epub 2011 Jul 11.

12.

Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease.

Vermeiren Y, Le Bastard N, Clark CM, Engelborghs S, De Deyn PP.

Neurochem Res. 2011 Oct;36(10):1858-62. doi: 10.1007/s11064-011-0504-4. Epub 2011 May 20.

PMID:
21597934
13.

Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors.

Blasko I, Kemmler G, Jungwirth S, Wichart I, Weissgram S, Jellinger K, Tragl KH, Fischer P.

J Neural Transm. 2011 May;118(5):663-72. doi: 10.1007/s00702-011-0599-4. Epub 2011 Feb 23.

PMID:
21344239
14.

Serum clusterin levels are not increased in presymptomatic Alzheimer's disease.

IJsselstijn L, Dekker LJ, Koudstaal PJ, Hofman A, Sillevis Smitt PA, Breteler MM, Luider TM.

J Proteome Res. 2011 Apr 1;10(4):2006-10. doi: 10.1021/pr101221h. Epub 2011 Feb 22.

PMID:
21280673
15.

The 32-year relationship between cholesterol and dementia from midlife to late life.

Mielke MM, Zandi PP, Shao H, Waern M, Östling S, Guo X, Björkelund C, Lissner L, Skoog I, Gustafson DR.

Neurology. 2010 Nov 23;75(21):1888-95. doi: 10.1212/WNL.0b013e3181feb2bf. Epub 2010 Nov 10.

16.

Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.

Schupf N, Zigman WB, Tang MX, Pang D, Mayeux R, Mehta P, Silverman W.

Neurology. 2010 Nov 2;75(18):1639-44. doi: 10.1212/WNL.0b013e3181fb448b.

17.

Ultrafiltrate of blood plasma modulates amyloid-β aggregation.

Nowicka A, Szczepankiewicz AA, Jaklewicz A, Filipek A, Barcikowska M, Elbaum D.

J Alzheimers Dis. 2011;23(1):1-5. doi: 10.3233/JAD-2010-101137.

PMID:
20930295
18.

Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease.

Blasko I, Kemmler G, Jungwirth S, Wichart I, Krampla W, Weissgram S, Jellinger K, Tragl KH, Fischer P.

Am J Geriatr Psychiatry. 2010 Nov;18(11):973-82. doi: 10.1097/JGP.0b013e3181df48be.

PMID:
20808106
19.

Premature centromere division of metaphase chromosomes in peripheral blood lymphocytes of Alzheimer's disease patients: relation to gender and age.

Zivković L, Spremo-Potparević B, Plecas-Solarović B, Djelić N, Ocić G, Smiljković P, Siedlak SL, Smith MA, Bajić V.

J Gerontol A Biol Sci Med Sci. 2010 Dec;65(12):1269-74. doi: 10.1093/gerona/glq148. Epub 2010 Aug 30.

20.

Plasma carbonic anhydrase II protein is elevated in Alzheimer's disease.

Jang BG, Yun SM, Ahn K, Song JH, Jo SA, Kim YY, Kim DK, Park MH, Han C, Koh YH.

J Alzheimers Dis. 2010;21(3):939-45. doi: 10.3233/JAD-2010-100384.

PMID:
20634585
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk